Department of Obstetrics and Gynecology, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
Department of Gynecology and Obstetrics, Karlsruhe Municipal Hospital, Karlsruhe, Germany.
Acta Obstet Gynecol Scand. 2022 Jul;101(7):771-778. doi: 10.1111/aogs.14374. Epub 2022 May 5.
Cryopreservation of ovarian tissue with subsequent transplantation is an efficient option for restoring fertility in women at risk of premature ovarian failure. The association between infertility and endometriosis is well recognized. Although endometriosis usually ends with the onset of natural or iatrogen menopause due to declining estrogen levels, endometriosis can in rare cases occur after menopause. This study aims to investigate women with premature menopause who were diagnosed with endometriosis during laparoscopy for ovarian tissue transplantation, and to address the questions of how endometriotic lesions after cytotoxic treatment and premature menopause might be explained, whether endometriosis affects pregnancy rates, and whether there is an association between endometriosis and the original cancer.
Seventeen patients who had undergone ovarian tissue transplantation to restore their fertility and who were diagnosed with endometriosis during transplantation were included in this retrospective study. The endometriosis foci were completely removed and ovarian tissue was transplanted into the pelvic peritoneum. Preexisting conditions, use of hormonal preparations, endometriosis stage pain assessment, as well as pregnancy and live birth rate were evaluated.
The mean age of the patients was 29.5 ± 6.3 years (range 14-39) at the time of ovarian tissue harvest and 34.6 ± 4.3 years (range 28-40) at transplantation. Prior to transplantation, four patients had taken hormone replacement therapy, four women oral contraceptives and two patients' tamoxifen. Twelve women had stage I endometriosis and five stage II endometrioses according to the rASRM classification. Four patients reported dysmenorrhea. None of the women complained of general pelvic pain or dyspareunia. The pregnancy rate in the study population was 41.2%, with a live birth rate of 35.3%. The pregnancies occurred in three cases after spontaneous conception, in four women after a natural cycle IVF/ICSI.
This study highlights the under-researched association between endometriosis in women entering premature or early menopause either after gonadotoxic treatment or due to primary ovarian insufficiency. As more and more patients seek to have their cryopreserved ovarian tissue transplanted to fulfill their desire to have children, specialists will inevitably encounter women with this condition.
卵巢组织冷冻保存后再移植是一种有效的方法,可以恢复有卵巢早衰风险的女性的生育能力。不孕与子宫内膜异位症的关系是众所周知的。虽然由于雌激素水平下降,子宫内膜异位症通常会随着自然或医源性绝经的发生而结束,但在极少数情况下,绝经后也可能发生子宫内膜异位症。本研究旨在探讨在接受卵巢组织移植的腹腔镜检查中被诊断为子宫内膜异位症的过早绝经女性,并探讨以下问题:细胞毒性治疗后和过早绝经后出现的子宫内膜异位病变如何解释,子宫内膜异位症是否会影响妊娠率,以及子宫内膜异位症与原始癌症之间是否存在关联。
本回顾性研究纳入了 17 名接受卵巢组织移植以恢复生育能力并在移植过程中被诊断为子宫内膜异位症的患者。完全切除子宫内膜异位病灶,并将卵巢组织移植到盆腔腹膜。评估了患者的既往病史、激素制剂的使用、子宫内膜异位症分期疼痛评估以及妊娠和活产率。
患者的平均年龄为 29.5±6.3 岁(范围 14-39 岁),在卵巢组织采集时为 34.6±4.3 岁(范围 28-40 岁)。在移植前,4 名患者接受了激素替代治疗,4 名患者服用了口服避孕药,2 名患者服用了他莫昔芬。根据 rASRM 分类,12 名患者患有Ⅰ期子宫内膜异位症,5 名患者患有Ⅱ期子宫内膜异位症。4 名患者有痛经。没有患者抱怨一般性盆腔疼痛或性交痛。研究人群的妊娠率为 41.2%,活产率为 35.3%。妊娠发生在 3 例自然受孕、4 例自然周期 IVF/ICSI 后的患者中。
本研究强调了在接受性腺毒性治疗或因原发性卵巢功能不全而进入过早或早期绝经的女性中,子宫内膜异位症的关联性研究不足。随着越来越多的患者寻求将其冷冻保存的卵巢组织移植以实现生育愿望,专家们将不可避免地遇到患有这种疾病的患者。